🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
IDXX
NASDAQ
🇺🇸 US
IDEXX Laboratories
Healthcare
52Score
DipBuster Score™
$556.20
+$11.88 (+2.18%)
Live price · Source: Yahoo
52-Week Position
$518.55
15% of range
$769.98
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
BetaN/A
52W High$769.98
52W Low$518.55
DipBuster Brief
Key signals at a glance
Zone: Buy Zone
Bullish
Near 52-Week Low — Wide Margin of Safety
At 15% of its annual range the stock is near its floor, offering value investors a cushion before fundamentals need to re-rate.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position15% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta—
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at IDEXX Laboratories (IDXX), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-06-01 | Fennell George | SELL | 639 |
| 2026-06-01 | Fennell George | SELL | 284 |
| 2026-06-01 | Fennell George | BUY | 639 |
| 2026-05-12 | Peacock Karen | BUY | 234 |
| 2026-05-12 | Peacock Karen | BUY | 525 |
| 2026-05-12 | Samad Sam | BUY | 234 |
| 2026-05-12 | Samad Sam | BUY | 525 |
| 2026-05-12 | Britt Irene Chang | BUY | 234 |
| 2026-05-12 | Britt Irene Chang | BUY | 525 |
| 2026-05-12 | Vandebroek Sophie V. | BUY | 234 |
Valuation
P/E RatioN/A
Market CapN/A
BetaN/A
Dividend/yrNone
52W High$769.98
52W Low$518.55
52-Week Range
$518.55Now$769.98
15% through annual range
From 52W High−27.8%
From 52W Low+7.3%
📖 Plain English Summary
IDEXX Laboratories is at 15% of its 52-week range.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for IDXX
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — IDXX
Heuristic · balance sheet, insider filings, price data, academic research
IDEXX Laboratories — DipBuster Score 52/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track IDEXX Laboratories free
Add IDXX to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
34/25
Momentum & Volume
13/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
11
/100 · NEUTRAL
dip depth
11/25
oversold rsi
0/25
mean reversion
0/15
insider zone
0/25
capitulation
0/10
Technical signal only. Not financial advice.
Quick Take
🟢
Dip Signal
DipBuster Score: 52/100
📈
Strong recent momentum — price and volume trending in the right direction.